Pharma Design

pharmadesign.co.uk

Pharma Design are specialists in providing pharmaceutical packaging artworks for the pharmaceutical, biotech and healthcare industry. Pharma Design is the most experienced 'pharma only' artwork specialist company in the UK - independently established since July 2005 and we continue to operate independent and 100% pharma-only focused.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharmacy Market

THERALINK® TECHNOLOGIES EXPANDS ADOPTION OF ITS PRECISION MEDICINE TECHNOLOGY IN THE BIOPHARMACEUTICAL INDUSTRY

Theralink Technologies | April 20, 2022

news image

Theralink Technologies a precision medicine company with a novel phosphoprotein-based assay for breast cancer, today announced that it has significantly expanded the adoption of its Laser Capture Microdissection and Reverse Phase Protein Array precision medicine technology to biopharmaceutical companies, including multinational healthcare corporations. The Company has supported 41 preclinical and clinical studies for 18 biopharma companies and is currently undergoing discussions to develop Compa...

Read More

Research

MODERNA AND MEDISON PHARMA COLLABORATE TO COMMERCIALIZE MODERNA'S COVID-19 VACCINE IN CENTRAL EASTERN EUROPE AND ISRAEL

Moderna | June 08, 2021

news image

Moderna, Inc., a biotechnology company that pioneered messenger RNA (mRNA) therapeutics and vaccines, and Medison Pharma, a leading commercial partner for highly innovative therapies in international markets, announced today a new agreement to commercialize the Moderna COVID-19 Vaccine in Central Eastern Europe and Israel. Poland, Czech Republic, Romania, Hungary, Bulgaria, Slovenia, Slovakia, Croatia, Estonia, Latvia, Lithuania, Serbia, Ukraine, Moldova, Albania, Bosnia, and Herz...

Read More

NO SINGLE MANUFACTURER CAN MEET CORONAVIRUS VACCINE GLOBAL DEMAND, SAYS MODERNA CEO

Cnbc | May 13, 2020

news image

Moderna CEO Stephane Bancel said Tuesday that he hopes many coronavirus vaccines from multiple manufacturers will be approved to enter the market, because no single manufacturer can meet global demand. Regeneron CEO Leonard Schleifer, whose company is devel...

Read More

Pharmacy Market

ICON SELECTED BY BARDA TO CONDUCT ANTHRAX VACCINE CLINICAL TRIAL

ICON plc | October 07, 2022

news image

ICON plc. a world-leading healthcare intelligence and clinical research organisation, announces that it has been selected by the US Biomedical Advanced Research and Development Authority part of the Administration for Strategic Preparedness and Response in the Department of Health and Human Services to execute an anthrax vaccine clinical trial. BARDA is providing funding to the Government and Public Health Solutions team at ICON to develop and execute a clinical trial that will ev...

Read More
news image

Pharmacy Market

THERALINK® TECHNOLOGIES EXPANDS ADOPTION OF ITS PRECISION MEDICINE TECHNOLOGY IN THE BIOPHARMACEUTICAL INDUSTRY

Theralink Technologies | April 20, 2022

Theralink Technologies a precision medicine company with a novel phosphoprotein-based assay for breast cancer, today announced that it has significantly expanded the adoption of its Laser Capture Microdissection and Reverse Phase Protein Array precision medicine technology to biopharmaceutical companies, including multinational healthcare corporations. The Company has supported 41 preclinical and clinical studies for 18 biopharma companies and is currently undergoing discussions to develop Compa...

Read More
news image

Research

MODERNA AND MEDISON PHARMA COLLABORATE TO COMMERCIALIZE MODERNA'S COVID-19 VACCINE IN CENTRAL EASTERN EUROPE AND ISRAEL

Moderna | June 08, 2021

Moderna, Inc., a biotechnology company that pioneered messenger RNA (mRNA) therapeutics and vaccines, and Medison Pharma, a leading commercial partner for highly innovative therapies in international markets, announced today a new agreement to commercialize the Moderna COVID-19 Vaccine in Central Eastern Europe and Israel. Poland, Czech Republic, Romania, Hungary, Bulgaria, Slovenia, Slovakia, Croatia, Estonia, Latvia, Lithuania, Serbia, Ukraine, Moldova, Albania, Bosnia, and Herz...

Read More
news image

NO SINGLE MANUFACTURER CAN MEET CORONAVIRUS VACCINE GLOBAL DEMAND, SAYS MODERNA CEO

Cnbc | May 13, 2020

Moderna CEO Stephane Bancel said Tuesday that he hopes many coronavirus vaccines from multiple manufacturers will be approved to enter the market, because no single manufacturer can meet global demand. Regeneron CEO Leonard Schleifer, whose company is devel...

Read More
news image

Pharmacy Market

ICON SELECTED BY BARDA TO CONDUCT ANTHRAX VACCINE CLINICAL TRIAL

ICON plc | October 07, 2022

ICON plc. a world-leading healthcare intelligence and clinical research organisation, announces that it has been selected by the US Biomedical Advanced Research and Development Authority part of the Administration for Strategic Preparedness and Response in the Department of Health and Human Services to execute an anthrax vaccine clinical trial. BARDA is providing funding to the Government and Public Health Solutions team at ICON to develop and execute a clinical trial that will ev...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us